Back
ESC Professional Premium Access

30-day outcomes of P2Y12 inhibitor pretreatment in patients with STEMI submitted to primary PCI - systematic review and meta-analysis

Session: Antithrombotic and anticoagulant therapy
Topic: Pharmacotherapy
Speaker: Doctor J. Presume (Lisbon, PT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Joao Presume

Hospital Santa Cruz, Lisbon (Portugal)
0 follower

8 more presentations in this session

Associations between DAPT score and long-term mortality post PCI

Speaker: Doctor M. Tan (Melbourne, AU)

Access
Abstract
Slides
Like
Thumbnail

Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk

Speaker: Doctor S. Lahu (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials

Speaker: Doctor S. Alexiou (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trials

Speaker: Doctor F. Costa (Messina, IT)

Access
Abstract
Slides
Like
Thumbnail

Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.

Speaker: Doctor S. Lee (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Antithrombotic and anticoagulant therapy

Speakers: Doctor J. Presume, Doctor M. Tan, Doctor S. Lahu, Doctor S. Alexiou, Doctor F. Costa...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources